LIPAC Oncology
Business Services · California, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
325 Sharon Park Dr Ste 739, Menlo Park, ...Phone Number
(909) 595-0500Website
www.lipaconcology.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About LIPAC Oncology
LIPAC Oncology is a clinical-stage company specializing in precision targeted, locally delivered taxane technology for cancer treatment. Their innovative pipeline addresses significant unmet needs in various cancer types, including bladder cancer, malignant pleural effusion, upper tract urothelial carcinoma, stage II/III ovarian cancer, and intraperitoneal carcinoma. The company is dedicated to creating life-saving treatment options for cancer patients through advanced research and development. LIPAC Oncology aims to improve outcomes for patients facing localized cancer tumors.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is LIPAC Oncology your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once LIPAC Oncology has new funding data
Congratulate Masked Content for being promoted to Masked Content at LIPAC Oncology
Earning: See what the market has to say on LIPAC Oncology recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if LIPAC Oncology had a recent Job posting/layoffs
Check out if LIPAC Oncology is spiking on competitors!
Product Launch: Get notified when LIPAC Oncology launches new products
LIPAC Oncology, which may be a good buyer, showed buying intent in Masked Content Topic
Check if LIPAC Oncology has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to LIPAC Oncology
Compare insights from companies similar to LIPAC Oncology, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
LIPAC Oncology
<$5M
1-10
Private
$5M
2016
N/A
Company Profile Activity
Activity Insights
LIPAC Oncology is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
LIPAC Oncology is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about LIPAC Oncology.
LIPAC Oncology financials insights
Gather financial insights about LIPAC Oncology, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Other Financing Round
$5M
LIPAC Oncology Tech Stack
A closer look at the technologies used by LIPAC Oncology
Most Recent Scoops
New Hire
Executive Move
LIPAC Oncology has announced that Robert Fuladi has joined the organization as Chief Strategy Officer.
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Funding
Funding
LIPAC Oncology News & Media
LIPAC Oncology Secures Broad Patent Protection for Proliposomal Paclitaxel Compositions Formulated for Delivery to the Bladder and Ureter for the Treatment of Solid Tumor Carcinomas
MENLO PARK, Calif., Oct. 7, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the U.S. Patent and Trademark Office...LIPAC Oncology to Present at Upcoming Investor Conferences
MENLO PARK, Calif., Sept. 21, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced that management will participate in...LIPAC Oncology Announces Two-Year Recurrence Free Survival Data for Phase 1/2a Study of LiPax in Patients With Non-Muscle Invasive Bladder Cancer
MENLO PARK, Calif., June 9, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its next generation precision liposomal technology to locally deliver taxanes to target tissues, today announced the positive results from the two-year follow-up for TD-001, its Phase...LIPAC Oncology Names Daniel K. Spiegelman as Independent Board Advisor
MENLO PARK, Calif., May 13, 2021 /PRNewswire/ -- LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Daniel K....
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding LIPAC Oncology
Sign Up For FreeTo access detailed company insights
LIPAC Oncology is a clinical-stage company specializing in precision targeted, locally delivered taxane technology for cancer treatment. Their innovative pipeline addresses significant unmet needs in various cancer types, including bladder cancer, malignant pleural effusion, upper tract urothelial carcinoma, stage II/III ovarian cancer, and intrape... Read More
